UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Randomized phase III study comparing best supportive care to biafine as a prophylactic agent for radiation-induced skin toxicity for women undergoing breast irradiation: Radiation therapy oncology group (RTOG) 97-13

International journal of radiation oncology, biology, physics, 2000-12, Vol.48 (5), p.1307-1310

2000

Volltextzugriff (PDF)

Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: report of Radiation Therapy Oncology Group Protocol 85-31

Journal of clinical oncology, 1997-03, Vol.15 (3), p.1013-1021

1997

Volltextzugriff (PDF)

Phase III radiation therapy oncology group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate

International journal of radiation oncology, biology, physics, 2001-08, Vol.50 (5), p.1243-1252

2001

Volltextzugriff (PDF)

Predicting long-term survival, and the need for hormonal therapy: a meta-analysis of RTOG prostate cancer trials

International journal of radiation oncology, biology, physics, 2000-06, Vol.47 (3), p.617-627

2000

Volltextzugriff (PDF)

Updated results of the phase III Radiation Therapy Oncology Group (RTOG) trial 85-31 evaluating the potential benefit of androgen suppression following standard radiation therapy for unfavorable prognosis carcinoma of the prostate

International journal of radiation oncology, biology, physics, 2001-03, Vol.49 (4), p.937-946

2001

Volltextzugriff (PDF)

Four prognostic groups predict long-term survival from prostate cancer following radiotherapy alone on radiation therapy oncology group clinical trials

International journal of radiation oncology, biology, physics, 2000-06, Vol.47 (3), p.609-615

2000

Volltextzugriff (PDF)

p53 Status and Prognosis of Locally Advanced Prostatic Adenocarcinoma: a Study Based on RTOG 8610

JNCI : Journal of the National Cancer Institute, 1997-01, Vol.89 (2), p.158-165

1997

Volltextzugriff (PDF)

Loss of p16 Expression Is of Prognostic Significance in Locally Advanced Prostate Cancer: An Analysis From the Radiation Therapy Oncology Group Protocol 86–10

Journal of clinical oncology, 2003-09, Vol.21 (17), p.3328-3334

2003

Volltextzugriff (PDF)

LONG-TERM SURVIVAL AFTER RADIOTHERAPY ALONE: RADIATION THERAPY ONCOLOGY GROUP PROSTATE CANCER TRIALS

The Journal of urology, 1999-03, Vol.161 (3), p.864-868

1999

Volltextzugriff (PDF)

Tissue Micro-Array: A Cost and Time-Effective Method for Correlative Studies by Regional and National Cancer Study Groups

Modern pathology, 2002-12, Vol.15 (12), p.1366-1373

2002

Volltextzugriff (PDF)

Does androgen suppression enhance the efficacy of postoperative irradiation? A secondary analysis of RTOG 85-31

Urology (Ridgewood, N.J.), 1999-09, Vol.54 (3), p.495-502

1999

Volltextzugriff (PDF)

Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: a randomized comparative trial of the radiation therapy oncology group

Urology (Ridgewood, N.J.), 1995-04, Vol.45 (4), p.616-623

1995

Volltextzugriff (PDF)

Impact of Surgical Staging in Evaluating the Radiotherapeutic Outcome in RTOG 77-06, a phase III Study for T1BN0M0 (A 2) and T2N0M0 (B) Prostate Carcinoma

International journal of radiation oncology, biology, physics, 1998-03, Vol.40 (4), p.769-782

1998

Volltextzugriff (PDF)

Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate: analysis of RTOG studies 7506 and 7706

International journal of radiation oncology, biology, physics, 1991-09, Vol.21 (4), p.935-939

1991

Volltextzugriff (PDF)

Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma—long-term results of phase III RTOG 85–31

International journal of radiation oncology, biology, physics, 2005-04, Vol.61 (5), p.1285-1290

2005

Volltextzugriff (PDF)

Elective pelvic irradiation in stage A2, B carcinoma of the prostate: analysis of RTOG 77-06

International journal of radiation oncology, biology, physics, 1988-12, Vol.15 (6), p.1307-1316

1988

Volltextzugriff (PDF)

Patterns of care and rtog studies in prostate cancer: Long-term survival, hazard rate observations, and possibilities of cure

International journal of radiation oncology, biology, physics, 1994, Vol.28 (1), p.39-45

1994

Volltextzugriff (PDF)

Correlation of radiotherapeutic parameters and treatment related morbidity—analysis of RTOG study 77-06

International journal of radiation oncology, biology, physics, 1987-07, Vol.13 (7), p.1007-1012

1987

Volltextzugriff (PDF)

Ten-Year Outcomes for Pathologic Node-Positive Patients Treated in RTOG 75-06

International journal of radiation oncology, biology, physics, 1998-03, Vol.40 (4), p.765-768

1998

Volltextzugriff (PDF)

Survival Advantage From Higher-Dose Radiation Therapy for Clinically Localized Prostate Cancer Treated on the Radiation Therapy Oncology Group Trials

Journal of clinical oncology, 2000-07, Vol.18 (14), p.2740-2746

2000

Volltextzugriff (PDF)

Phase II trial of hormonal cytoreduction with megestrol and diethylstilbestrol in conjunction with radiotherapy for carcinoma of the prostate: Outcome results of RTOG 83-07

International journal of radiation oncology, biology, physics, 1995-04, Vol.32 (1), p.175-180

1995

Volltextzugriff (PDF)

Correlation of radiotherapeutic parameters and treatment related morbidity in carcinoma of the prostate— analysis of rtog study 75-06

International journal of radiation oncology, biology, physics, 1987-03, Vol.13 (3), p.351-357

1987

Volltextzugriff (PDF)

Prognostic factors in carcinoma of the prostate— analysis of rtog study 75-06

International journal of radiation oncology, biology, physics, 1987-03, Vol.13 (3), p.339-349

1987

Volltextzugriff (PDF)

Androgen suppression plus radiation versus radiation alone for patients with D1 (pN+) adenocarcinoma of the prostate (results based on a national prospective randomized trial, RTOG 85-31)

International journal of radiation oncology, biology, physics, 1997-07, Vol.38 (5), p.931-939

1997

Volltextzugriff (PDF)

Androgen Suppression Plus Radiation Versus Radiation Alone for Patients With Stage D 1 /Pathologic Node-Positive Adenocarcinoma of the Prostate: Updated Results Based on National Prospective Randomized Trial Radiation Therapy Oncology Group 85-31

Journal of clinical oncology, 2005-02, Vol.23 (4), p.800-807

2005

Volltextzugriff (PDF)

1 – 25 von 159

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(154)
Mit Volltextzugriff
(136)

Publikationsform

Artikel
(158)
Buchkapitel
(1)

Sprache

Englisch
(158)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(106)
Male
(94)
Life Sciences & Biomedicine
(88)
Science & Technology
(88)
Oncology
(69)
Biological And Medical Sciences
(66)
Medical Sciences
(66)
Prostatic Neoplasms - Radiotherapy
(59)
Radiology, Nuclear Medicine & Medical Imaging
(50)
Aged
(46)
Middle Aged
(46)
Nephrology. Urinary Tract Diseases
(37)
Tumors Of The Urinary System
(35)
Urinary Tract. Prostate Gland
(35)
Radiotherapy
(31)
Female
(30)
Prostatic Neoplasms - Pathology
(30)
Prognosis
(24)
Adult
(23)
Prostatic Neoplasms - Mortality
(23)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Randomized phase III study comparing best supportive care to biafine as a prophylactic agent for radiation-induced skin toxicity for women undergoing breast irradiation: Radiation therapy oncology group (RTOG) 97-13

Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: report of Radiation Therapy Oncology Group Protocol 85-31

Phase III radiation therapy oncology group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate

Predicting long-term survival, and the need for hormonal therapy: a meta-analysis of RTOG prostate cancer trials

Updated results of the phase III Radiation Therapy Oncology Group (RTOG) trial 85-31 evaluating the potential benefit of androgen suppression following standard radiation therapy for unfavorable prognosis carcinoma of the prostate

Four prognostic groups predict long-term survival from prostate cancer following radiotherapy alone on radiation therapy oncology group clinical trials

p53 Status and Prognosis of Locally Advanced Prostatic Adenocarcinoma: a Study Based on RTOG 8610

Loss of p16 Expression Is of Prognostic Significance in Locally Advanced Prostate Cancer: An Analysis From the Radiation Therapy Oncology Group Protocol 86–10

LONG-TERM SURVIVAL AFTER RADIOTHERAPY ALONE: RADIATION THERAPY ONCOLOGY GROUP PROSTATE CANCER TRIALS

Tissue Micro-Array: A Cost and Time-Effective Method for Correlative Studies by Regional and National Cancer Study Groups

Does androgen suppression enhance the efficacy of postoperative irradiation? A secondary analysis of RTOG 85-31

Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: a randomized comparative trial of the radiation therapy oncology group

Impact of Surgical Staging in Evaluating the Radiotherapeutic Outcome in RTOG 77-06, a phase III Study for T1BN0M0 (A 2) and T2N0M0 (B) Prostate Carcinoma

Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate: analysis of RTOG studies 7506 and 7706

Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma—long-term results of phase III RTOG 85–31

Elective pelvic irradiation in stage A2, B carcinoma of the prostate: analysis of RTOG 77-06

Patterns of care and rtog studies in prostate cancer: Long-term survival, hazard rate observations, and possibilities of cure

Correlation of radiotherapeutic parameters and treatment related morbidity—analysis of RTOG study 77-06

Ten-Year Outcomes for Pathologic Node-Positive Patients Treated in RTOG 75-06

Survival Advantage From Higher-Dose Radiation Therapy for Clinically Localized Prostate Cancer Treated on the Radiation Therapy Oncology Group Trials

Phase II trial of hormonal cytoreduction with megestrol and diethylstilbestrol in conjunction with radiotherapy for carcinoma of the prostate: Outcome results of RTOG 83-07

Correlation of radiotherapeutic parameters and treatment related morbidity in carcinoma of the prostate— analysis of rtog study 75-06

Prognostic factors in carcinoma of the prostate— analysis of rtog study 75-06

Androgen suppression plus radiation versus radiation alone for patients with D1 (pN+) adenocarcinoma of the prostate (results based on a national prospective randomized trial, RTOG 85-31)

Androgen Suppression Plus Radiation Versus Radiation Alone for Patients With Stage D 1 /Pathologic Node-Positive Adenocarcinoma of the Prostate: Updated Results Based on National Prospective Randomized Trial Radiation Therapy Oncology Group 85-31

Suchergebnisse filtern